Generics in the United Kingdom

Generics in the United Kingdom

Code: ML-OHME5037 | Published: Jan-2016 | Pages: 34 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Kingdom generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the generic-eligible market, are not included.

- The UK generics market is expected to generate total revenues of $8.2bn in 2015, representing a compound annual growth rate (CAGR) of 9.4% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 85.8 % of total pharma volume in 2015.

- The UK healthcare market is reliant on generics to provide cost savings, especially in recent years as healthcare spending has been cut. According to the British Generic Manufacturers Association (BGMA), the average cost to the NHS of a generic medicine is Pound3.79. Comparatively, the average cost of a branded medicine is Pound19.73. The reliance on cost-effective generic medicines should see the market continue to grow.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in the United Kingdom

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in the United Kingdom

Leading company profiles reveal details of key generics market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom generics market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the United Kingdom economy

Reasons To Buy
What was the size of the United Kingdom generics market by value in 2015?

What will be the size of the United Kingdom generics market in 2020?

What factors are affecting the strength of competition in the United Kingdom generics market?

How has the market performed over the last five years?

How large is the United Kingdoms generics market in relation to its regional counterparts?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market volume 9
Market Segmentation 10
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Market volume forecast 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Allergan plc 19
Mylan Inc. 22
Sandoz International GmbH 25
Teva Pharmaceutical Industries Limited 26
Macroeconomic Indicators 29
Country Data 29
Methodology 31
Industry associations 32
Related MarketLine research 32
Appendix 33
About MarketLine 33

List of Tables
Table 1: United Kingdom generics market value: $ billion, 2011-15(e)
Table 2: United Kingdom generics market volume: % of total pharma volume, 2011-15(e)
Table 3: United Kingdom generics market geography segmentation: $ billion, 2015(e)
Table 4: United Kingdom generics market value forecast: $ billion, 2015-20
Table 5: United Kingdom generics market volume forecast: % of total pharma volume, 2015-20
Table 6: Allergan plc: key facts
Table 7: Allergan plc: key financials ($)
Table 8: Allergan plc: key financial ratios
Table 9: Mylan Inc.: key facts
Table 10: Mylan Inc.: key financials ($)
Table 11: Mylan Inc.: key financial ratios
Table 12: Sandoz International GmbH: key facts
Table 13: Teva Pharmaceutical Industries Limited: key facts
Table 14: Teva Pharmaceutical Industries Limited: key financials ($)
Table 15: Teva Pharmaceutical Industries Limited: key financial ratios
Table 16: United Kingdom size of population (million), 2011-15
Table 17: United Kingdom gdp (constant 2005 prices, $ billion), 2011-15
Table 18: United Kingdom gdp (current prices, $ billion), 2011-15
Table 19: United Kingdom inflation, 2011-15
Table 20: United Kingdom consumer price index (absolute), 2011-15
Table 21: United Kingdom exchange rate, 2011-15

List of Figures
Figure 1: United Kingdom generics market value: $ billion, 2011-15(e)
Figure 2: United Kingdom generics market volume: % of total pharma volume, 2011-15(e)
Figure 3: United Kingdom generics market geography segmentation: % share, by value, 2015(e)
Figure 4: United Kingdom generics market value forecast: $ billion, 2015-20
Figure 5: United Kingdom generics market volume forecast: % of total pharma volume, 2015-20
Figure 6: Forces driving competition in the generics market in the United Kingdom, 2015
Figure 7: Drivers of buyer power in the generics market in the United Kingdom, 2015
Figure 8: Drivers of supplier power in the generics market in the United Kingdom, 2015
Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2015
Figure 10: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2015
Figure 11: Drivers of degree of rivalry in the generics market in the United Kingdom, 2015
Figure 12: Allergan plc: revenues and profitability
Figure 13: Allergan plc: assets and liabilities
Figure 14: Mylan Inc.: revenues and profitability
Figure 15: Mylan Inc.: assets and liabilities
Figure 16: Teva Pharmaceutical Industries Limited: revenues and profitability
Figure 17: Teva Pharmaceutical Industries Limited: assets and liabilities
Allergan plc, Mylan Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Limited

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine

Our Clients